<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="snse-20241025.xsd" xlink:type="simple"/>
    <context id="duration_2024-10-25_to_2024-10-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001829802</identifier>
        </entity>
        <period>
            <startDate>2024-10-25</startDate>
            <endDate>2024-10-25</endDate>
        </period>
    </context>
    <context id="duration_2024-10-25_to_2024-10-25_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001829802</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-25</startDate>
            <endDate>2024-10-25</endDate>
        </period>
    </context>
    <context id="duration_2024-10-25_to_2024-10-25_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001829802</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-10-25</startDate>
            <endDate>2024-10-25</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2024-10-25_to_2024-10-25" id="ixv-216">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2024-10-25_to_2024-10-25"
      id="Hidden_dei_EntityCentralIndexKey">0001829802</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2024-10-25_to_2024-10-25" id="ixv-243">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2024-10-25_to_2024-10-25" id="ixv-244">2024-10-25</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2024-10-25_to_2024-10-25" id="ixv-245">Sensei Biotherapeutics, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2024-10-25_to_2024-10-25" id="ixv-246">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2024-10-25_to_2024-10-25" id="ixv-247">001-39980</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2024-10-25_to_2024-10-25" id="ixv-248">83-1863385</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2024-10-25_to_2024-10-25" id="ixv-249">1405 Research Blvd</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="duration_2024-10-25_to_2024-10-25" id="ixv-250">Suite 125</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="duration_2024-10-25_to_2024-10-25" id="ixv-251">Rockville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2024-10-25_to_2024-10-25" id="ixv-252">MD</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2024-10-25_to_2024-10-25" id="ixv-253">20850</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2024-10-25_to_2024-10-25" id="ixv-254">(240)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2024-10-25_to_2024-10-25" id="ixv-255">243-8000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2024-10-25_to_2024-10-25" id="ixv-256">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2024-10-25_to_2024-10-25" id="ixv-257">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2024-10-25_to_2024-10-25" id="ixv-258">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2024-10-25_to_2024-10-25" id="ixv-259">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="duration_2024-10-25_to_2024-10-25_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember"
      id="ixv-260">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="duration_2024-10-25_to_2024-10-25_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember"
      id="ixv-261">SNSE</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="duration_2024-10-25_to_2024-10-25_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember"
      id="ixv-262">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="duration_2024-10-25_to_2024-10-25_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember"
      id="ixv-263">Series A Preferred Stock Purchase Rights</dei:Security12bTitle>
    <dei:SecurityExchangeName
      contextRef="duration_2024-10-25_to_2024-10-25_us-gaap-StatementClassOfStockAxis_us-gaap-SeriesAPreferredStockMember"
      id="ixv-264">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2024-10-25_to_2024-10-25" id="ixv-265">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="duration_2024-10-25_to_2024-10-25" id="ixv-266">false</dei:EntityExTransitionPeriod>
</xbrl>
